Peer Review History
Original SubmissionApril 19, 2021 |
---|
PONE-D-21-13007 "He who pays the piper calls the tune": Researcher experiences of funder suppression of health behaviour intervention trial findings PLOS ONE Dear Dr. McCrabb, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your manuscript was very well received by the reviewers and they largely note minor revisions for clarity. Please also address the outstanding queries regarding recruitment and some of the nuances in terms of interpretation (or limits of interpretation) regarding what suppression actually entails. One of the reviewers suggests a novel analysis by region/country, which I would ask you to consider or respond to. I look forward to receiving your revision. Please submit your revised manuscript by Jul 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Quinn Grundy, PhD, RN Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting and important paper but I have a number of suggestions for improvement. It reports the extent to which funders of studies attempt to suppress publication of unfavourable results, which is a highly important topic. Major comments: Recruitment part slightly unclear: “We invited the first two authors, the last author, and the corresponding author, using contact information in the public domain, to complete the survey. Authors with available contact details were invited to complete a telephone interview.” If they were contacted they all had contact details available – what does this last sentence mean? How was it actually decided whether to do interview or survey? Did you only do interview where phone number was available? Why not email to arrange phone interview and ask for number then? Were questions the same? It would be helpful to know what “reluctance” actually signifies. Funders shouldn’t be able to affect whether findings are published – did responses suggest that funders could actually prevent publication or just tried to influence? A related point is that it would be very interesting to know how researchers dealt with suppression attempts – particularly attacks on the research team. Generally the discussion (which is rather short) and/or results would benefit from more detail on the details of suppression attempts and how they were handled, if these data are available. Minor comments: Abstract should mention other aspects apart from supression specifically to give readers an idea of other behaviours. Some minor lack of clarity in places, eg. “improve smoking/substance abuse ” Why these specific health intervention areas and not others? A rationale should be given. Were respondents able to suggest other types of suppression activity? There may be other types not mentioned in your survey. Reviewer #2: This is an excellent and timely paper that is well written and comes to an important and well justified set of recommendations. I have only a few minor comments that will clarify the presentation and improve the general context of the research and interpretation. I think it would be more usual to put the . after the references, such as [1, 2]. 77-83. You could further improve the context by referring to the recent study on science suppression in ecology by Driscoll et al. 2020 in Conservation Letters, relevant because it addresses suppression in public good research in Australia. 98. researchers' 203. insert "the odds ratios of" at the start of this line. 211-12. Is it worth reporting these extreme values, as neither is likely to be true, or even close to true? 224-5. That is a reasonable interpretation. 226. Hold on, you said at 201-2 that older studies had higher rates of suppression. Some extra words in the results to help interpret direction of effect in relation to the odds ratio would help readers and the authors to avoid this mix up. 228. It's a bit confusing to combine older and north American in this sentence, giving the impression it was only older north American studies, but these tests were independent, so it's old studies everywhere, and any aged study in north America. 235-6; or north American researchers are more afraid to report suppression. Or you could look at the European countries that your studies came from to see if they include less democratic countries. In fact, in addition to the regional analysis, it would be interesting to examine the likelihood of suppression in relation to the global democracy index, which extends back to 2006, so could be aligned with the year each paper was published, or the year before. 251; spell out what that would mean, what kind of clauses must be excluded from contracts or included for example. Also, in this list of actions, be clear about who should it for each point. It might also refer to other literature where similar lists of actions have been referred to (this might be best done in the list or as an introduction to the list). It would be nice to wrap up with a general, bigger picture paragraph about interference in public good research. I couldn't see if the data were available, which Plos seems to require. Reviewer #3: This was a very clear, concise and well-presented paper. It highlights a key aspect of research suppression, namely pressure from funders to produce and publish findings that align with the priorities of the day. It was necessarily narrow in scope. However, it would be interesting to know whether respondents experienced suppression events from parties other than the funding body. In my experience, public health fields are particularly prone to silencing from within. It also would have been interesting to include discussion of the broader, more insidious suppression that chronically underfunded public research produces. As noted in the authors' limitations section, it is impossible to ascertain the number of researchers whose work is suppressed before it has even begun. The unspoken or whispered warnings to keep one's head down; stick to something safer; only 'pick winners'. We know in Australia for example, that it is not worth writing a grant funding proposal that suggests the government's alcohol guidelines are not conducive to responsible drinking, or that school-based fitness programs may actually be counter-productive. The only suggestions I would make are: -Page 5, line 98 contains a missing apostrophe. It should read "researchers' experiences" -Page 6, lines 129-130, title of Box 1 is convoluted. Consider renaming to “Options respondents were provided regarding funder behaviour” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Dr Jacqueline Hoepner [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
"He who pays the piper calls the tune": Researcher experiences of funder suppression of health behaviour intervention trial findings PONE-D-21-13007R1 Dear Dr. McCrabb, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Quinn Grundy, PhD, RN Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-21-13007R1 “He who pays the piper calls the tune”: Researcher experiences of funder suppression of health behaviour intervention trial findings Dear Dr. McCrabb: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Quinn Grundy Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .